Together, these subgroup analyses show an increased amount of TIGIT+ and PVRIG+ cytotoxic CD56dimCD16+ NK cells, whereas the regulatory CD56brightCD16− population expresses higher levels of CD39 and CD38 in AML in comparison to HDs. This evidence concerns the gene CD38 and acute myeloid leukemia.